Comparison of serum alkaline phosphatase levels between two measurement methods in chronic hemodialysis patients in Japan: involvement of ABO blood group system and relationship with mortality risk-Reference-Cited by-同舟云学术

Comparison of serum alkaline phosphatase levels between two measurement methods in chronic hemodialysis patients in Japan: involvement of ABO blood group system and relationship with mortality risk

Published:2024-08-07 Issue: Volume: Page:
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Nagano Nobuo^ORCID,Tagahara Ayaka,Shimada Takahito,Miya Masaaki,Tamei Noriko,Muto Shigeaki,Tsutsui Takaaki,Saito Daiki,Itami Shusaku,Ogawa Tetsuya,Ito Kyoko

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10157-024-02540-4.pdf

Reference28 articles.

1. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2006;69:1945–53.

2. Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama JJ, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17:247–88.

3. Izzo C, Secondulfo C, Bilancio G, Visco V, Virtuoso N, Migliarino S, et al. Chronic kidney disease with mineral bone disorder and vascular calcification: an overview. Life (Basel). 2024;14:418.

4. Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, McAllister CJ, et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol. 2008;19:2193–203.

5. Blayney MJ, Pisoni RL, Bragg-Gresham JL, Bommer J, Piera L, Saito A, et al. High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int. 2008;74:655–63.